These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4941315)

  • 1. Antigenic and immunogenic capacities of cell membranes with and without antilymphocyte serum.
    Matolo NM; Reemtsma K; DeWitt CW
    Surg Forum; 1971; 22():282-4. PubMed ID: 4941315
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cell membranes with and without antilymphocyte serum on skin and heart allograft survival.
    Matolo NM; Reemtsma K; Dewitt CW
    Transplantation; 1972 Mar; 13(3):265-9. PubMed ID: 4553728
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance and suppressor T cells.
    Brent L
    Proc Eur Dial Transplant Assoc; 1977; 14():245-50. PubMed ID: 341124
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of antilymphocyte serum on the antigen-binding cells of the blood and the survival of skin grafts].
    Dinoeva S
    Eksp Med Morfol; 1976; 15(2):89-95. PubMed ID: 776589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different sensitivity of H-2K and H-2D incompatibility to ALS immunosuppression.
    Démant P; Nouza K
    Folia Biol (Praha); 1971; 17(6):410-3. PubMed ID: 4400221
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac and skin heterograft rejection: suppression with antilymphocyte serum.
    Donawick WJ; Shaffer CF; Dodd DC; Buchanan JW; Fregin GF
    Transplant Proc; 1971 Mar; 3(1):551-3. PubMed ID: 4937937
    [No Abstract]   [Full Text] [Related]  

  • 7. Passenger cells in rat heart allografts. No effect of removal.
    Nielsen HE; Heron I; Koch C
    Transplantation; 1975 Apr; 19(4):360-3. PubMed ID: 1098240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antilymphocyte serum: methods for its preparation and measurement in vitro of its biological activity].
    Tursi A
    Haematologica; 1970 Dec; 55(12):766-73. PubMed ID: 5003116
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of skin allograft rejection by antilymphocytic serum pretreatment of the donor. Immunological preparation of the graft.
    Petrányi G; Szegedi G; Fekete B
    Acta Med Acad Sci Hung; 1971; 28(2):155-8. PubMed ID: 4948114
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolongation of the survival of primary and secondary allografts in rats using antilymphocyte serum].
    Kirzon SS; Khundanov LL; Verbitskiĭ MSh; Nastoiashchaia NN
    Biull Eksp Biol Med; 1972 Apr; 73(4):90-1. PubMed ID: 4555188
    [No Abstract]   [Full Text] [Related]  

  • 11. Connection between the anti-organ and anti-nuclear titres of antilymphocyte sera and their inhibitory effect on skin graft rejection in mice.
    Fekete B; Petrányi G; Szegedi G; Szabó G
    Haematologia (Budap); 1971; 5(4):419-23. PubMed ID: 4948255
    [No Abstract]   [Full Text] [Related]  

  • 12. Complications in prolonged administration of antilymphocytic sera.
    Koumans RK; Billote JB; Burke JF
    Transplant Proc; 1971 Mar; 3(1):807-10. PubMed ID: 4937973
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of cross-species sensitization between skin allo- and xenotransplants in mice.
    Vizler C; Jánossy T; Tabi Z; Végh P
    Transplant Proc; 1994 Jun; 26(3):1324-5. PubMed ID: 8029925
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart transplantation in congenic strains of mice.
    Corry RJ; Winn HJ; Russell PS
    Transplant Proc; 1973 Mar; 5(1):733-5. PubMed ID: 4572133
    [No Abstract]   [Full Text] [Related]  

  • 15. An experimental model for hyperacute rejection in inbred rat cardiac transplantation: correlation cardiac graft survival time and anti T-cell warm cytotoxic antibody titer.
    Dohi K; Tabe Y; Ezaki H
    Hiroshima J Med Sci; 1984 Jun; 33(2):251-7. PubMed ID: 6384146
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac transplantation in mice. IV. Relationship between antithymocyte-globulin (ATG) dose, allograft survival and anti-ATG immunity.
    Judd KP; Bryant CJ; Ruckman RJ; Trentin JJ
    Rev Eur Etud Clin Biol; 1971 Dec; 16(10):1002-6. PubMed ID: 4400851
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
    Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
    Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
    [No Abstract]   [Full Text] [Related]  

  • 18. What's new in surgery. Transplantation.
    Williams GM
    Surg Gynecol Obstet; 1973 Feb; 136(2):212-5. PubMed ID: 4568747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies on the effect of antilymphocyte serum (ALS) and of proteolytic inhibitors on the survival time of skin transplants in rabbits].
    Fidelski R; Niedworok J; Tchórzewski H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(2):231-5. PubMed ID: 4111657
    [No Abstract]   [Full Text] [Related]  

  • 20. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.